45.62
price down icon4.36%   -2.08
pre-market  Pre-market:  46.40   0.78   +1.71%
loading
Tonix Pharmaceuticals Holding Corp stock is traded at $45.62, with a volume of 1.44M. It is down -4.36% in the last 24 hours and up +28.58% over the past month. Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
See More
Previous Close:
$47.70
Open:
$46.77
24h Volume:
1.44M
Relative Volume:
1.27
Market Cap:
$335.64M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-4.0515
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
+18.13%
1M Performance:
+28.58%
6M Performance:
+305.87%
1Y Performance:
-0.31%
1-Day Range:
Value
$44.36
$48.50
1-Week Range:
Value
$35.66
$48.50
52-Week Range:
Value
$7.31
$130.00

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Name
Name
Tonix Pharmaceuticals Holding Corp
Name
Phone
212-980-9155
Name
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
Employee
81
Name
Twitter
@TONIXPharma
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
TNXP's Discussions on Twitter

Compare TNXP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
45.62 350.94M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
385.65 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.13 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
428.14 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.15 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
298.52 33.25B 3.81B -644.79M -669.77M -6.24

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-18-22 Initiated Noble Capital Markets Outperform
Apr-18-19 Upgrade ROTH Capital Neutral → Buy
Aug-18-17 Upgrade ROTH Capital Neutral → Buy
Sep-07-16 Downgrade ROTH Capital Buy → Neutral
Feb-17-16 Reiterated Oppenheimer Outperform
Nov-04-15 Initiated Cantor Fitzgerald Buy
Jun-12-15 Initiated Oppenheimer Outperform
Feb-17-15 Reiterated ROTH Capital Buy
Sep-29-14 Reiterated ROTH Capital Buy
View All

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News

pulisher
Aug 06, 2025

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga

Aug 06, 2025
pulisher
Aug 04, 2025

Tonix Pharmaceuticals Innovation: What’s Next? - timothysykes.com

Aug 04, 2025
pulisher
Aug 04, 2025

TNXP’s Race Against Time: Market Buzz Remains High​ - StocksToTrade

Aug 04, 2025
pulisher
Aug 04, 2025

Tonix Pharmaceuticals Holding Corp. Added to Custom Quant Screener TodayMarket Entry and Exit Point Tips From Traders - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 09:31:49 - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Tonix Pharmaceuticals Holding Corp. stockInvest confidently with professional market insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Tonix Pharmaceuticals Holding Corp. compare to its industry peersOutstanding growth strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Tonix Pharmaceuticals Holding Corp. stock expected to show significant growthFree AI-Backed Trading Signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Tonix Pharmaceuticals Holding Corp. company’s balance sheetCapitalize on high-yield stocks early - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Tonix Pharmaceuticals Holding Corp. stock in 2025Phenomenal wealth increase - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is Tonix Pharmaceuticals Holding Corp. a growth stock or a value stockUnprecedented growth rates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Published on: 2025-08-03 07:26:37 - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Does Tonix Pharmaceuticals Holding Corp. stock perform well during market downturnsDynamic profit opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How volatile is Tonix Pharmaceuticals Holding Corp. stock compared to the marketUnlock high-yield investment opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Why is Tonix Pharmaceuticals Holding Corp. stock attracting strong analyst attentionWealth Building Opportunities For Beginners - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

What are the technical indicators suggesting about Tonix Pharmaceuticals Holding Corp.Chart Pattern Report Backed By Experts - Jammu Links News

Aug 01, 2025
pulisher
Jul 30, 2025

Key resistance and support levels for Tonix Pharmaceuticals Holding Corp.Early Entry Picks Before News Breakout Reviewed - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Tonix launches Move Fibro Forward campaign to support millions living with Fibromyalgia - Proactive financial news

Jul 30, 2025
pulisher
Jul 30, 2025

Price Channel Expanding on Tonix Pharmaceuticals Holding Corp.’s ChartLow Risk Swing Trade Opportunities Identified - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500 - Smartkarma

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 17:18:40 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500… - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 07:17:10 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What are Tonix Pharmaceuticals Holding Corp. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Tonix Pharmaceuticals Holding Corp. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Tonix Pharmaceuticals Holding Corp. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Tonix Pharmaceuticals Holding Corp. stock price move sharplyHigh-return market picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Tonix Pharmaceuticals Holding Corp. stock is on top investor watchlistsFree Market Dynamics Reports - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Published on: 2025-07-26 12:35:26 - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Tonix Pharmaceuticals Holding Corp. Stock Analysis and ForecastUnprecedented growth rates - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Tonix Pharma’s Unexpected Rise in Stock Value - timothysykes.com

Jul 25, 2025
pulisher
Jul 25, 2025

Is TNXP Stock Ready for Takeoff? - StocksToTrade

Jul 25, 2025
pulisher
Jul 25, 2025

Is Tonix Pharmaceuticals Holding Corp. a good long term investmentAccelerated profit realization - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Tonix Pharmaceuticals Holding Corp. stock priceHigh-yield market plays - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Tonix Pharmaceuticals Holding Corp. stockFree High-Return Strategy Alerts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight - The Malaysian Reserve

Jul 24, 2025

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.65
price down icon 0.10%
$37.12
price down icon 2.08%
$111.26
price down icon 0.31%
$28.52
price down icon 2.09%
$111.30
price up icon 0.21%
biotechnology ONC
$298.52
price down icon 2.84%
Cap:     |  Volume (24h):